BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30079782)

  • 21. [Resolution of the HPV Vaccine Working Group of December 12, 2006].
    Vonka V; Hamsíková E;
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):94-8. PubMed ID: 17593807
    [No Abstract]   [Full Text] [Related]  

  • 22. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary HPV vaccine results for women older than 25 years.
    Harper DM
    Lancet; 2009 Jun; 373(9679):1921-2. PubMed ID: 19501728
    [No Abstract]   [Full Text] [Related]  

  • 24. [Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].
    Vaccine and Immunization Branch, Chinese Preventive Medicine Association
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Dec; 53(12):1218-1235. PubMed ID: 31795578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bivalent HPV Recombinant Vaccine (Cervarix) for the Prevention of Cervical Cancer.
    Schauner S; Lyon C
    Am Fam Physician; 2010 Dec; 82(12):1541-2. PubMed ID: 21166376
    [No Abstract]   [Full Text] [Related]  

  • 26. The HPV vaccine for men.
    O'Connor MB; O'Connor C
    Int J STD AIDS; 2009 Apr; 20(4):290-1. PubMed ID: 19304982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 29. HPV vaccination.
    Dilley S; Miller K; Huh W
    Gynecol Oncol; 2018 Jan; 148(1):3-4. PubMed ID: 29246414
    [No Abstract]   [Full Text] [Related]  

  • 30. Cervical cancer and prevention by vaccination: results from recent trials.
    Tjalma WA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x217-23. PubMed ID: 17018727
    [No Abstract]   [Full Text] [Related]  

  • 31. The future of cervical cancer prevention: human papillomavirus vaccines.
    Cadman L
    J Fam Health Care; 2008; 18(4):131-2. PubMed ID: 18754553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
    Michelow P; Firnhaber C
    Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
    [No Abstract]   [Full Text] [Related]  

  • 33. HPV vaccination: should it be mandatory for entry into public school?
    Gray JR
    Nurs Womens Health; 2007 Apr; 11(2):133-8. PubMed ID: 17883794
    [No Abstract]   [Full Text] [Related]  

  • 34. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 35. HPV prevention update. New vaccine offers additional options.
    Klisz C; Kaplan C
    Adv Nurse Pract; 2009 Nov; 17(11):28-9, 54. PubMed ID: 20014688
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data used to justify Indian HPV vaccination trial questioned.
    Bhaumik S
    Lancet Oncol; 2012 Aug; 13(8):e330. PubMed ID: 23024991
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.